Curcumin in cancer therapy: Exploring molecular mechanisms and overcoming clinical challenges
Cancer Letters · 2023-08 · 570 · 216332
DOI: 10.1016/j.canlet.2023.216332 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2023-08. Verfasst von Wei Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611…. Hauptthemen laut MEDLINE: Curcumin, Neoplasms. Die Arbeit wurde bisher 161-mal zitiert (Crossref) und nennt 123 Literaturangaben. Gefördert von: National University of Singapore, National Medical Research Council, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
Cancer poses a significant global health burden, necessitating the widespread use of chemotherapy and radiotherapy as conventional frontline interventions. Although targeted therapy and immunotherapy have shown remarkable advancements, the challenges of resistance development and severe side effects persist in cancer treatment. Consequently, researchers have actively sought more effective alternatives with improved safety profiles. In recent years, curcumin, a natural polyphenolic phytoalexin, has garnered considerable attention due to its broad spectrum of biological effects. This concise review provides valuable insights into the role of curcumin in cancer therapy, with a focus on elucidating its molecular mechanisms in inducing programmed cell death of tumor cells and suppressing tumor cell metastasis potential. Additionally, we discuss the challenges associated with the clinical application of curcumin and explore current endeavors aimed at overcoming these limitations. By shedding light on the promising potential of curcumin, this review contributes to the advancement of cancer treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
- Department of Medical Cardiology, Zhongxiang TCM Hospital of Hubei, Zhongxiang, 431900, China.
- Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117600, Si…
- State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China. Electronic address: chenlu@cdutcm.edu.cn.
Förderung
- National University of Singapore
- National Medical Research Council
- Natural Science Foundation of Sichuan Province
- Chengdu University of Traditional Chinese Medicine
- National Research Foundation Singapore
- Ministry of Education - Singapore
- State Administration of Traditional Chinese Medicine of the People's Republic of China
- Cancer Science Institute of Singapore
Zitieren
APA
Wang, W., Li, M., Wang, L., Chen, L., & Goh, B. C. (2023). Curcumin in cancer therapy: Exploring molecular mechanisms and overcoming clinical challenges. Cancer Letters, 570, 216332. https://doi.org/10.1016/j.canlet.2023.216332
Vancouver
Wang W, Li M, Wang L, Chen L, Goh BC. Curcumin in cancer therapy: Exploring molecular mechanisms and overcoming clinical challenges. Cancer Letters. 2023;570:216332. doi:10.1016/j.canlet.2023.216332
BibTeX
@article{Wang2023,
author = {Wang, Wei and Li, Mingqin and Wang, Lingzhi and Chen, Lu and Goh, Boon-Cher},
title = {Curcumin in cancer therapy: Exploring molecular mechanisms and overcoming clinical challenges},
journal = {Cancer Letters},
year = {2023},
volume = {570},
pages = {216332},
doi = {10.1016/j.canlet.2023.216332}
}
EUVIMED